{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5.6","upperLimit":"10.7","value":"9.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"}],"units":"Participants"}],"description":"From the date of enrollment until the date of death due to any cause. Patients last known to be alive were censored at the date of last contact.","dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"AZD2171"}],"paramType":"MEDIAN","populationDescription":"Eligible patients who received AZD2171","reportingStatus":"POSTED","timeFrame":"Daily during protocol treatment; then every 8 weeks until progression; then every 6 months for up to 3 years.","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"months"}